Role of High Mobility Group Box 1 in Cardiovascular Diseases

Souad Belmadani1, Khalid Matrougui2

  • 1Department of Physiological Sciences, EVMS, Norfolk, Virginia, 23501, USA.

Inflammation
|April 7, 2022
PubMed

Insights

High Mobility Group Box 1 (HMGB1) protein, crucial in inflammation, is increasingly linked to cardiovascular diseases. Understanding HMGB1

Area of Science:

  • Molecular Biology
  • Immunology
  • Cardiology

Background:

  • High Mobility Group Box 1 (HMGB1) is a conserved protein with nuclear, cytosolic, and extracellular functions.
  • HMGB1's role in inflammation is established, but its specific involvement in cardiovascular diseases requires further elucidation.
  • Cellular localization and posttranslational modifications influence HMGB1's diverse biological activities.

Purpose of the Study:

  • To review recent findings on the pathophysiological connection between HMGB1 and cardiovascular complications.
  • To emphasize the role of inflammation in HMGB1-mediated cardiovascular effects.
  • To explore the potential of HMGB1-based therapeutic strategies for cardiovascular diseases.

Main Methods:

  • Literature review of recent scientific reports and studies.
  • Analysis of existing data on HMGB1's function in cellular signaling and secretion.
  • Focus on studies linking HMGB1 to inflammatory processes in the cardiovascular system.

Main Results:

  • HMGB1 translocates from the nucleus to the cytoplasm and is secreted extracellularly.
  • Evidence suggests a significant role for HMGB1 in the inflammatory pathways underlying cardiovascular complications.
  • The precise mechanisms of HMGB1's involvement in cardiovascular disease pathogenesis are under active investigation.

Conclusions:

  • HMGB1 is implicated in the development and progression of cardiovascular diseases through inflammatory mechanisms.
  • Further research into HMGB1's function is crucial for understanding cardiovascular pathology.
  • Targeting HMGB1 may offer novel therapeutic avenues for treating cardiovascular conditions.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
99
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
75
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
62
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
2.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
122
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
93